Sarah A. Dugger

593 total citations
5 papers, 349 citations indexed

About

Sarah A. Dugger is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sarah A. Dugger has authored 5 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 1 paper in Genetics and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Sarah A. Dugger's work include CRISPR and Genetic Engineering (2 papers), RNA Research and Splicing (2 papers) and Amyotrophic Lateral Sclerosis Research (1 paper). Sarah A. Dugger is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), RNA Research and Splicing (2 papers) and Amyotrophic Lateral Sclerosis Research (1 paper). Sarah A. Dugger collaborates with scholars based in United States, Australia and Canada. Sarah A. Dugger's co-authors include David B. Goldstein, Adam Platt, Michael J. Boland, Sahar Gelfman, Wayne N. Frankel, Slavé Petrovski, Ayal B. Gussow, Quanli Wang, Shelton S. Bradrick and K. Melodi McSweeney and has published in prestigious journals such as Nature Reviews Drug Discovery, Genome Research and PLoS Genetics.

In The Last Decade

Sarah A. Dugger

5 papers receiving 343 citations

Peers

Sarah A. Dugger
Serene Josiah United States
Chonlarat Wichaidit United States
Kate M. O’Neill United States
Sandrine Ferrand Switzerland
Jon A. Oyer United States
Laurent Winckers Netherlands
Paloma Ruiz United States
Zhengqiu Zhou United States
Graeme Benstead-Hume United Kingdom
Robyn Loureiro United States
Serene Josiah United States
Sarah A. Dugger
Citations per year, relative to Sarah A. Dugger Sarah A. Dugger (= 1×) peers Serene Josiah

Countries citing papers authored by Sarah A. Dugger

Since Specialization
Citations

This map shows the geographic impact of Sarah A. Dugger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Dugger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Dugger more than expected).

Fields of papers citing papers by Sarah A. Dugger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Dugger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Dugger. The network helps show where Sarah A. Dugger may publish in the future.

Co-authorship network of co-authors of Sarah A. Dugger

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Dugger. A scholar is included among the top collaborators of Sarah A. Dugger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Dugger. Sarah A. Dugger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Dugger, Sarah A., Ryan S. Dhindsa, Gabriela Louise de Almeida Sampaio, et al.. (2023). Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency. PLoS Genetics. 19(10). e1010952–e1010952. 6 indexed citations
2.
Dugger, Sarah A., et al.. (2022). Evidence of shared transcriptomic dysregulation of HNRNPU-related disorder between human organoids and embryonic mice. iScience. 26(1). 105797–105797. 4 indexed citations
3.
Gelfman, Sahar, Sarah A. Dugger, Cristiane Araújo Martins Moreno, et al.. (2019). A new approach for rare variation collapsing on functional protein domains implicates specific genic regions in ALS. Genome Research. 29(5). 809–818. 14 indexed citations
4.
Dugger, Sarah A., Adam Platt, & David B. Goldstein. (2017). Drug development in the era of precision medicine. Nature Reviews Drug Discovery. 17(3). 183–196. 293 indexed citations
5.
McSweeney, K. Melodi, Ayal B. Gussow, Shelton S. Bradrick, et al.. (2016). Inhibition of microRNA 128 promotes excitability of cultured cortical neuronal networks. Genome Research. 26(10). 1411–1416. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serene Josiah Breakdown of academic impact, for papers by Chonlarat Wichaidit Breakdown of academic impact, for papers by Kate M. O’Neill Breakdown of academic impact, for papers by Sandrine Ferrand Breakdown of academic impact, for papers by Jon A. Oyer Breakdown of academic impact, for papers by Laurent Winckers Breakdown of academic impact, for papers by Paloma Ruiz Breakdown of academic impact, for papers by Zhengqiu Zhou Breakdown of academic impact, for papers by Graeme Benstead-Hume Breakdown of academic impact, for papers by Robyn Loureiro
Rankless by CCL
2026